A Cross-Sectional Study on Resistivity Index of Renal Vasculature in Patients with Cirrhosis of Liver in a Tertiary Care Centre
Authors/Creators
- 1. Assistant Professor, Department of General Medicine, Osmania Medical College / Hospital, Hyderabad, TS
- 2. Associate Professor, Department of General Medicine, SVS Medical College, Mahabubnagar, TS
- 3. Associate Professor, SVS Medical College, Mahabubnagar, TS
Description
Aim of the Study: To study resistivity Index of Renal Vasculature in Patients with Cirrhosis of Liver in A Tertiary Care Centre. Material & Methods: A total of 92 patients in which there were 75 cases which included cirrhosis with ascites, cirrhosis without ascites and 17 controls which included fatty liver and healthy individuals formed the study group. Results: The study group is a total of 92 patients, 49 were cirrhosis with ascites patients, 26 were cirrhosis without ascites patients, 17 healthy which includes fatty liver. In our study, Resistivity index is increased in both cirrhosis with ascites and without ascites. So early phase itself shows increased Resistivity Index. Resistivity Index was significantly higher in ascitic patients compared to non-ascitic patients (0.74 vs. 0.67, p<0.01) and in non-ascitic patients with liver cirrhosis than in control subjects (0.67 vs. 0.62, p<0.01). In our study Resistivity Index was significantly higher in ascitic patients compared to non-ascitic patients (0.87 vs. 0.76, p<0.01) and in non-ascitic patients with liver cirrhosis than in control subjects (0.76 vs. 0.64, p<0.001). Conclusion: Renal vasoconstriction evaluated by these indices is correlated with Child score which quantitatively measures the hepatic function in cirrhosis. The diagnosis of elevated Resistivity Index may be taken into account in the clinical management of these patients.
Abstract (English)
Aim of the Study: To study resistivity Index of Renal Vasculature in Patients with Cirrhosis of Liver in A Tertiary Care Centre. Material & Methods: A total of 92 patients in which there were 75 cases which included cirrhosis with ascites, cirrhosis without ascites and 17 controls which included fatty liver and healthy individuals formed the study group. Results: The study group is a total of 92 patients, 49 were cirrhosis with ascites patients, 26 were cirrhosis without ascites patients, 17 healthy which includes fatty liver. In our study, Resistivity index is increased in both cirrhosis with ascites and without ascites. So early phase itself shows increased Resistivity Index. Resistivity Index was significantly higher in ascitic patients compared to non-ascitic patients (0.74 vs. 0.67, p<0.01) and in non-ascitic patients with liver cirrhosis than in control subjects (0.67 vs. 0.62, p<0.01). In our study Resistivity Index was significantly higher in ascitic patients compared to non-ascitic patients (0.87 vs. 0.76, p<0.01) and in non-ascitic patients with liver cirrhosis than in control subjects (0.76 vs. 0.64, p<0.001). Conclusion: Renal vasoconstriction evaluated by these indices is correlated with Child score which quantitatively measures the hepatic function in cirrhosis. The diagnosis of elevated Resistivity Index may be taken into account in the clinical management of these patients.
Files
IJPCR,Vol15,Issue4,Article225.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bfea62fe08ec9618143465b4e32a52d2
|
1.2 MB | Preview Download |
Additional details
Dates
- Accepted
-
2023-03-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue4,Article225.pdf
- Development Status
- Active
References
- 1. Xu X, Ling Q, Zhang M, et al.Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation. May 27, 2009; 87(10): 1514-9. 2. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. Jan 1996; 76-164 (: 1)23. 3. Fabrizi F, Dixit V, Messa P, Martin P. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials. Int J Artif OrgansMar 2009;32(3):133- 40. 4. Umgelter A, Schmid RM. [Terlipressin for hepatorenal syndrome - what is the role of plasma expansion and hemodynamic monitoring?]. Z Gastroenterol Mar 2009;47(3):307-8. 5. Can J Gastroenterol. 2004 Feb; 18(2): 121-2. Am J Gastroenterol. 2002 Aug; 97(8):1868-70 6. Intrarenal arterial doppler ultrasonography in cirrhotic patients with ascites, with and without hepatorenal syndrome] Rev Med Chil. 2002 Feb; 1. 7. Renal failure in cirrhosis. N Engl J Med. 2009 Sep 24; 361(13):1279-90. 8. Platt JF, Ellis JH, Rubin JM, Merion RM, Lucey MR: Renal duplex Doppler ultrasonography: A noninvasive predictor of kidney dysfunction hepatorenal failure in liver disease. Hepatology. 1994; 20:362 –369. 9. Epstein M, Berk DP, Hollenberg NK, et al: Renal failure in the patient with cirrhosis the role of active vasoconstriction. Am J Med. 1970; 49:175.10. Colli A, Cocciolo M, Riva C, et al: Abnormal renovascular impedance in patients with hepatic cirrhosis: Detection with duplex US. Radiology. 1993; 187:561. 11. Arroyo V, Bataller R, Guevara M. Treatment of hepatorenal syndrome in cirrhosis. In: Arroyo V, Gines P, Rodes J, Schrier RW, editors. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis, and treatment. Malden (MA): Blackwell Science, 1999;492–510. 12. Iwatsuki S, Popovtzer MM, Corman JL, et al. Recovery from hepatorenal syndrome after orthotopic liver transplantation. N Engl J Med. 1973; 289: 11559.